Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleIs It Really Happening?

1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?

Uwe Haberkorn, Annette Altmann, Frederik L. Giesel and Clemens Kratochwil
Journal of Nuclear Medicine October 2024, 65 (10) 1518-1520; DOI: https://doi.org/10.2967/jnumed.124.267923
Uwe Haberkorn
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany;
3Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette Altmann
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frederik L. Giesel
4Department of Nuclear Medicine, Medical Faculty and University Hospital Duesseldorf, Duesseldorf, Germany; and
5Institute for Radiation Sciences, Osaka University, Toyonaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clemens Kratochwil
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 10 1518-1520
DOI 
https://doi.org/10.2967/jnumed.124.267923
PubMed 
39168520

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 3, 2024
  • Accepted for publication July 23, 2024
  • Published online October 1, 2024.

Article Versions

  • previous version (August 21, 2024 - 07:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?
    Rodney J. Hicks
    Journal of Nuclear Medicine 2025 66 4
  • Non-[18F]FDG PET-Radiopharmaceuticals in Oncology
    Antonia Dimitrakopoulou-Strauss, Leyun Pan, Christos Sachpekidis
    Pharmaceuticals 2024 17 12
  • Patent spotlight on theranostics targeting fibroblast activation protein for personalized cancer care
    Jason A. Witek, Allen F. Brooks, Benjamin L. Viglianti, Peter J. H. Scott
    Pharmaceutical Patent Analyst 2025

Article usage

Article usage: August 2024 to May 2025

AbstractFullPdf
Aug 2024016699
Sep 202405946
Oct 20240974222
Nov 2024033769
Dec 2024017827
Jan 202509221
Feb 2025011349
Mar 2025010360
Apr 202509183
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (10)
Journal of Nuclear Medicine
Vol. 65, Issue 10
October 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
Uwe Haberkorn, Annette Altmann, Frederik L. Giesel, Clemens Kratochwil
Journal of Nuclear Medicine Oct 2024, 65 (10) 1518-1520; DOI: 10.2967/jnumed.124.267923

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
1,090 Publications and 5 Years Later: Is FAP-Targeted Theranostics Really Happening?
Uwe Haberkorn, Annette Altmann, Frederik L. Giesel, Clemens Kratochwil
Journal of Nuclear Medicine Oct 2024, 65 (10) 1518-1520; DOI: 10.2967/jnumed.124.267923
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • FAP LIGANDS FOR DIAGNOSIS
    • THERAPIES TARGETING FAP-EXPRESSING FIBROBLASTS
    • YOU NEVER TREAT ALONE
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?
  • Development of FAP-targeted theranostics discovered by next-generation sequencing-augmented mining of a novel immunized VNAR library
  • Google Scholar

More in this TOC Section

  • Is 211At Really Happening?
  • Are FAP Theranostics Really Happening? Will Radiochemistry or Biology Win?
  • SPECT Deserves RESPECT: The Potential of SPECT/CT to Optimize Patient Outcomes with Theranostics Therapy
Show more Is It Really Happening?

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire